Building on the findings of6, in this work we sought to explore whether an atlas based comparison approach could help identify shape differences in the prostate capsule as observed on pre-treatment T2 weighted MRI between prostate cancer patients who do (BCR+) and do not (BCR−) have BCR following definitive therapy. This evidence concerns the gene BCR and prostate carcinoma.